EICHORPublic-registry site landscape for NCT04315792, “Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients”, a Bipolar I Disorder study sponsored by Jina Pharmaceuticals Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04315792 (registry record) |
| Study title | Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients |
| Official title | A Double-blind, Oral, Multiple-dose, Parallel, Randomized Study to Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients |
| Sponsor | Jina Pharmaceuticals Inc. |
| Condition(s) | Bipolar I Disorder |
| Phase | PHASE3 |
| Listed sites | 1 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT04315792.
Eichor generates a preliminary site-risk snapshot for NCT04315792 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
